Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer

Clinical Cancer Research

Volumn 7, Issue 11, 2001, Pages 3385-3392

  Bing, Richard J ^a   Miyataka, Masaru ^a   Rich, Kathryn A ^a   Hanson, Nicholas ^a   Wang, Xuedong ^b   Slosser, Henry D ^b   Shi, Shan Rong ^c  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; PROSTANOID; THROMBOXANE A2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; COLON CANCER; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; THROMBOXANE B2;

EID: 0035175818     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Roads leading to breast cancer
2. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
3. The role of nitric oxide (NO) in the carcinogenic process
4. Roles of nitric oxide in tumor growth
5. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis
6. Arachidonic acid oxygenation by COX-1 and COX-2
7. Expression of nitric oxide synthase isoforms after myocardial infarction in humans
8. Nitric oxide synthase activity in human breast cancer
9. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
10. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells
11. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue
12. Selective expression of mitogen-inducible COX in macrophages stimulated with LPS
13. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
14. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
15. Prostaglandin, H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer
16. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
17. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
18. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
19. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
20. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
21. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
22. Aspirin use and potential mechanisms for colorectal cancer prevention
23. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
24. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
25. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis
26. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
27. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
28. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
29. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor
30. Chemotherapeutic evaluation of celecoxib, a COX-2 inhibitor, in a rat mammary tumor model
31. Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage
32. Nitric oxide activates cyclooxygenase enzymes
33. New look at myocardial infarction: Toward a better aspirin
34. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
35. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
36. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin
37. Host cyclooxygenase-2 modulates carcinoma growth
38. Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis
39. Thromboxane A2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis
40. Combinatorial chemoprevention of intestinal neoplasia
41. Colorectal cancer and non steroidal anti-inflammatory drugs
42. Is there a role for nitric oxide in tumor angiogenesis?
43. G-nitro-L-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors
44. Therapy of cancer metastasis by activation of the inducible nitric oxide synthase
45. Role of nitric oxide in angiogenesis and microcirculation in tumors
46. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation
47. The free radical formed during the hydroperoxide-mediated deactivation of ram seminal vesicles is hemoprotein-derived
48. Tumor induction of VEGF promoter activity in stromal cells
49. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP
50. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells
51. Is cyclooxygenase-2 the α and the ω in cancer?